Oxycodone News and Research

RSS
Controlled release pills and capsules with dose dumping tendency should be tested

Controlled release pills and capsules with dose dumping tendency should be tested

Acurox's New Drug Application discussed with the FDA

Acurox's New Drug Application discussed with the FDA

DURECT signs agreement with King Pharmaceuticals to supply two excipients for REMOXY

DURECT signs agreement with King Pharmaceuticals to supply two excipients for REMOXY

QRxPharma completes its pilot evaluation study investigating the efficacy of MoxDuo capsules

QRxPharma completes its pilot evaluation study investigating the efficacy of MoxDuo capsules

Medication safety program on safe prescribing procedures for narcotic drugs launched

Medication safety program on safe prescribing procedures for narcotic drugs launched

Orient Pharma granted commercialization rights for a drug candidate by DURECT

Orient Pharma granted commercialization rights for a drug candidate by DURECT

FDA acts to avoid shortage of medically necessary opioid

FDA acts to avoid shortage of medically necessary opioid

Opioid antagonists show potential for problematic pain

Opioid antagonists show potential for problematic pain

Oxycodone effective against shingles pain

Oxycodone effective against shingles pain

Research suggests those who have chronic pain may need to assess vitamin D status

Research suggests those who have chronic pain may need to assess vitamin D status

Opioid antagonists help pain management

Opioid antagonists help pain management

New guidelines for prescribing opioid pain drugs

New guidelines for prescribing opioid pain drugs

New guideline for prescribing opioid pain drugs published

New guideline for prescribing opioid pain drugs published

King Pharmaceuticals and Alpharma sign definitive merger agreement

King Pharmaceuticals and Alpharma sign definitive merger agreement

TheraQuest's IND for abuse deterrent strong opioid (TQ-1015) accepted by FDA

TheraQuest's IND for abuse deterrent strong opioid (TQ-1015) accepted by FDA

Extended suboxone treatment substantially improves outcomes for opioid-addicted young adults

Extended suboxone treatment substantially improves outcomes for opioid-addicted young adults

Abuse of painkillers can predispose adolescents to lifelong addiction

Abuse of painkillers can predispose adolescents to lifelong addiction

Minorities less likely to receive pain-relieving opioid drugs in ER

Minorities less likely to receive pain-relieving opioid drugs in ER

Watson Pharmaceuticals receives FDA approval for generic Combunox

Watson Pharmaceuticals receives FDA approval for generic Combunox

Medicaid pays for one-third of drug abuse hospitalizations

Medicaid pays for one-third of drug abuse hospitalizations